Literature DB >> 7125264

Comparative evaluation of intravenous agents for rapid sequence induction--thiopental, ketamine, and midazolam.

P F White.   

Abstract

The pharmacologic effects of ketamine, midazolam, and a midazolam-ketamine combination were compared with thiopental for rapid induction of general anesthesia. Thiopental, 4 mg/kg, 1.5 mg/kg ketamine, 0.3 mg/kg midazolam, or 0.15 mg/kg midazolam, and 0.75 mg/kg ketamine, were administered intravenously in a randomized fashion to 80 patients undergoing emergency surgery. Adequacy of induction, hemodynamic changes, and postoperative effects were assessed during and after a standardized induction-maintenance anesthetic technique. Midazolam had the slowest onset (15-60 s) and longest duration of action. During induction, thiopental decreased mean arterial pressure (MAP) by 11%, ketamine increased MAP by 10%, while neither midazolam nor the midazolam-ketamine combination significantly changed MAP. Heart rate (HR) increased during induction in all groups; however, the increase was significantly less in the combination group. After intubation, MAP and HR increased to the same extent in all four groups. Significantly more patients who received ketamine for induction were disoriented during emergence. Midazolam most effectively produced anxiolysis and antegrade amnesia. Significantly more patients who received thiopental felt depressed postoperatively, and 95% required parenteral opiate analgesics in the recovery room. Dreaming was highest after ketamine (55%) and lowest after midazolam (0%) and the combination (5%). Thus, midazolam effectively attenuated both the cardiostimulatory responses and unpleasant emergence reactions associated with ketamine. The author concludes that both midazolam and the midazolam-ketamine combination are safe and effective induction agents for emergency surgery, which may offer an advantage over thiopental in situations where hemodynamic stability is crucial. Furthermore, midazolam effectively attenuates the side effects of ketamine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7125264     DOI: 10.1097/00000542-198210000-00005

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  20 in total

Review 1.  When conventional asthma therapies fail.

Authors:  J Jones; S Murin
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

2.  Haemodynamic stability with midazolam-ketamine-sufentanil analgesia in cardiac surgical patients.

Authors:  S M Raza; R W Masters; E K Zsigmond
Journal:  Can J Anaesth       Date:  1989-11       Impact factor: 5.063

3.  Ketamine concentrations during cardiopulmonary bypass.

Authors:  R F McLean; A J Baker; S E Walker; C D Mazer; B I Wong; E M Harrington
Journal:  Can J Anaesth       Date:  1996-06       Impact factor: 5.063

4.  Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims.

Authors:  Michael Schönenberg; Ursula Reichwald; Gregor Domes; Andreas Badke; Martin Hautzinger
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

5.  Ketamine anesthesia.

Authors:  J R Werther
Journal:  Anesth Prog       Date:  1985 Sep-Oct

Review 6.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

7.  General anesthetics: a comparative review of pharmacodynamics.

Authors:  S B Milam
Journal:  Anesth Prog       Date:  1984 May-Jun

8.  Premedication with intramuscular midazolam: effect on induction time with intravenous midazolam compared to intravenous thiopentone or ketamine.

Authors:  A A Artru; M S Dhamee; A B Seifen
Journal:  Can Anaesth Soc J       Date:  1984-07

9.  Does haloperidol prophylaxis reduce ketamine-induced emergence delirium in children?

Authors:  Mostafa A M Amr; Tarek Shams; Hamid Al-Wadani
Journal:  Sultan Qaboos Univ Med J       Date:  2013-05-09

Review 10.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.